Skip to content

Clinical trials

Completed Phase 1/2 Neoplasms by Site trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Phase: Phase 1/2 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20112
20131
20172
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
AVEO Pharmaceuticals, Inc.1
Advanced Accelerator Applications1
BBB-Therapeutics B.V.1
BeiGene USA, Inc.1
Hoffmann-La Roche1
Isofol Medical AB1
Revolution Medicines, Inc.1
Steba Biotech S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site10
Neoplasms8
Lung Neoplasms4
Carcinoma3
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Gastrointestinal Neoplasms3
Lung Diseases3
Neoplasms by Histologic Type3
Respiratory Tract Diseases3

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.